首页> 美国卫生研究院文献>Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America >Relationship Between Alcohol Use Categories and Noninvasive Markers of Advanced Hepatic Fibrosis in HIV-Infected Chronic Hepatitis C Virus–Infected and Uninfected Patients
【2h】

Relationship Between Alcohol Use Categories and Noninvasive Markers of Advanced Hepatic Fibrosis in HIV-Infected Chronic Hepatitis C Virus–Infected and Uninfected Patients

机译:艾滋病毒感染慢性丙型肝炎病毒感染和未感染患者的酒精使用类别与晚期肝纤维化无创标记之间的关系

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background. It is unclear if the risk of liver disease associated with different levels of alcohol consumption is higher for patients infected with human immunodeficiency virus (HIV) or chronic hepatitis C virus (HCV). We evaluated associations between alcohol use categories and advanced hepatic fibrosis, by HIV and chronic HCV status.>Methods. We performed a cross-sectional study among participants in the Veterans Aging Cohort Study who reported alcohol consumption at enrollment (701 HIV/HCV-coinfected; 1410 HIV-monoinfected; 296 HCV-monoinfected; 1158 HIV/HCV-uninfected). Alcohol use category was determined by the Alcohol Use Disorders Identification Test–Consumption (AUDIT-C) questionnaire and alcohol-related diagnoses and was classified as nonhazardous drinking, hazardous/binge drinking, or alcohol-related diagnosis. Advanced hepatic fibrosis was defined by FIB-4 index >3.25.>Results. Within each HIV/HCV group, the prevalence of advanced hepatic fibrosis increased as alcohol use category increased. For each alcohol use category, advanced hepatic fibrosis was more common among HIV-infected than uninfected (nonhazardous: 6.7% vs 1.4%; hazardous/binge: 9.5% vs 3.0%; alcohol-related diagnosis: 19.0% vs 8.6%; P < .01) and chronic HCV-infected than uninfected (nonhazardous: 13.6% vs 2.5%; hazardous/binge: 18.2% vs 3.1%; alcohol-related diagnosis: 22.1% vs 6.5%; P < .01) participants. Strong associations with advanced hepatic fibrosis (adjusted odds ratio [95% confidence interval]) were observed among HIV/HCV-coinfected patients with nonhazardous drinking (14.2 [5.91–34.0]), hazardous/binge drinking (18.9 [7.98–44.8]), and alcohol-related diagnoses (25.2 [10.6–59.7]) compared with uninfected nonhazardous drinkers.>Conclusions. Advanced hepatic fibrosis was present at low levels of alcohol consumption, increased with higher alcohol use categories, and was more prevalent among HIV-infected and chronic HCV-infected patients than uninfected individuals. All alcohol use categories were strongly associated with advanced hepatic fibrosis in HIV/HCV-coinfected patients.
机译:>背景。目前尚不清楚感染人类免疫缺陷病毒(HIV)或慢性丙型肝炎病毒(HCV)的患者与不同饮酒量相关的肝病风险是否更高。我们通过HIV和慢性HCV状况评估了饮酒类别与晚期肝纤维化之间的关联。>方法。我们在退伍军人老龄队列研究参与者中进行了一项横断面研究,他们报告了入选时的饮酒情况( 701例HIV / HCV合并感染; 1410例HIV单一感染; 296例HCV单一感染; 1158例未感染HIV / HCV)。酒精使用类别由“酒精使用障碍识别测试-消费”(AUDIT-C)调查表和与酒精有关的诊断确定,并分为无危险饮酒,危险/暴饮或酒精相关诊断。晚期肝纤维化的定义是FIB-4指数> 3.25。>结果。在每个HIV / HCV组中,随着饮酒类别的增加,晚期肝纤维化的患病率增加。对于每种饮酒类别,HIV感染者中晚期肝纤维化比未感染者更为普遍(非危险性:6.7%vs 1.4%;危险/暴饮暴食:9.5%vs 3.0%;酒精相关性诊断:19.0%vs 8.6%; P < .01)和慢性HCV感染者比未感染者(无危险:13.6%vs 2.5%;危险/暴饮暴食:18.2%vs 3.1%;酒精相关诊断:22.1%vs 6.5%; P <0.01)。在感染了HIV / HCV的无危险饮酒(14.2 [5.91–34.0]),危险/无糖饮酒(18.9 [7.98-44.8])中,观察到与晚期肝纤维化密切相关(校正比值比[95%置信区间])。 ,以及与酒精相关的诊断(25.2 [10.6–59.7]),与未感染的非危险饮酒者相比。>结论。晚期肝纤维化的发生率较低,随酒精摄入量的增加而增加,并且在HIV感染者和慢性HCV感染者中比未感染者更普遍。在HIV / HCV合并感染的患者中,所有饮酒类别均与晚期肝纤维化密切相关。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号